IMZEPAR Trademark

Trademark Overview

On Wednesday, June 19, 2013, a trademark application was filed for IMZEPAR with the United States Patent and Trademark Office. The USPTO has given the IMZEPAR trademark a serial number of 79136717. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 19, 2023. This trademark is owned by UCB PHARMA S.A.. The IMZEPAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of central nervous system diseases and for the treatment of diseases of the immune system
imzepar

General Information

Serial Number79136717
Word MarkIMZEPAR
Filing DateWednesday, June 19, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 19, 2023
Registration Number4508736
Registration DateTuesday, April 8, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of central nervous system diseases and for the treatment of diseases of the immune system
Translation of Words in MarkThe wording "IMZEPAR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB BIOPHARMA SRL
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Friday, January 12, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, January 12, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, March 9, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, March 9, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Tuesday, November 17, 2020CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, April 8, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 26, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, September 4, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 16, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 24, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 24, 2014FINAL DISPOSITION PROCESSED
Tuesday, July 8, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 8, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Friday, January 17, 2014NOTIFICATION PROCESSED BY IB
Wednesday, January 1, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 1, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 1, 2014NOTICE OF PUBLICATION
Friday, December 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 2, 2013ASSIGNED TO LIE
Monday, November 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 25, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 14, 2013REFUSAL PROCESSED BY IB
Friday, October 18, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 18, 2013REFUSAL PROCESSED BY MPU
Thursday, October 17, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 16, 2013NON-FINAL ACTION WRITTEN
Wednesday, October 16, 2013APPLICATION FILING RECEIPT MAILED
Sunday, October 13, 2013ASSIGNED TO EXAMINER
Saturday, October 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 11, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 10, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

imzepar system treatment diseases immune nervous central preparations substances pharmaceutical